The Ohio State University
Biopharma with personalized cell therapy raises $45M in stock sale, forges ...MedCity NewsA company with the first FDA-approved personalized cell therapy for reducing wrinkles has raised $45 million in a private stock sale. The financing was sought to improve manufacturing capacity for the therapy and advance other uses for it such as ...See all stories on this topic »
